000			02293nam a22004575i 4500
001			978-1-60761-968-0
003			DE-He213
005			20140220083735.0
007			cr nn 008mamaa
008			101202s2011 xxu| s |||| 0|eng d
020			_a9781607619680 _9978-1-60761-968-0
024	7		_a10.1007/978-1-60761-968-0 _2doi
050		4	_aRC261-271
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a614.5999 _223
100	1		_aTeicher, Beverly A. _eeditor.
245	1	0	_aTumor Models in Cancer Research _h[electronic resource] / _cedited by Beverly A. Teicher.
250			_a2.
264		1	_aTotowa, NJ : _bHumana Press : _bImprint: Humana Press, _c2011.
300			_aXIV, 693p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aCancer Drug Discovery and Development
520			_aBeverly A. Teicher and a panel of leading experts comprehensively describe the state-of-the-art in animal tumor model research. This volume updates and extends the comprehensive presentations in the first edition. The wide array of models detailed form the basis for the selection of compounds and treatments that go into clinical testing of patients, and include syngeneic models, human tumor xenograft models, orthotopic models, metastatic models, and genetically engineered mouse models. Synthesizing many years experience with all the major in vivo models currently available for the study of malignant disease, Tumor Models in Cancer Research 2nd edition, provides preclinical and clinical cancer researchers alike with a comprehensive guide to the selection of these models, their effective use, and the optimal interpretation of their results.
650		0	_aMedicine.
650		0	_aOncology.
650		0	_aToxicology.
650	1	4	_aBiomedicine.
650	2	4	_aCancer Research.
650	2	4	_aPharmacology/Toxicology.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781607619673
830		0	_aCancer Drug Discovery and Development
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-60761-968-0
912			_aZDB-2-SME
999			_c106381 _d106381